Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Methods to Discover and Validate Biofluid-Based Biomarkers in Neurodegenerative Dementias
Charlotte E. Teunissen, Leighann Kimble, Sherif Bayoumy, et al.
Molecular & Cellular Proteomics (2023) Vol. 22, Iss. 10, pp. 100629-100629
Open Access | Times Cited: 20

Showing 20 citing articles:

Aggregation-Induced Emission Luminogen: Role in Biopsy for Precision Medicine
Yanhong Duo, Lei Han, Yaoqiang Yang, et al.
Chemical Reviews (2024) Vol. 124, Iss. 20, pp. 11242-11347
Open Access | Times Cited: 10
Fluid biomarkers in multiple sclerosis: from current to future applications
Massimiliano Di Filippo, Lorenzo Gaetani, Diego Centonze, et al.
The Lancet Regional Health - Europe (2024) Vol. 44, pp. 101009-101009
Open Access | Times Cited: 7
Neuroinflammation in Alzheimer disease
Wiesje M. van der Flier, Wiesje M. van der Flier, Frank Jessen, et al.
Nature reviews. Immunology (2024)
Closed Access | Times Cited: 6
Alcohol Use Disorder and Dementia: A Review
NM Zahr
Alcohol research (2024) Vol. 44, Iss. 1
Open Access | Times Cited: 5
Immunoassay detection of multiphosphorylated tau proteoforms as cerebrospinal fluid and plasma Alzheimer’s disease biomarkers
Anna Lidia Wojdaƚa, G. Bellomo, Lorenzo Gaetani, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
CSF biomarkers of B-cell activation in multiple sclerosis: a clinical perspective
Elena Di Sabatino, Diana Ferraro, Lorenzo Gaetani, et al.
Journal of Neurology (2025) Vol. 272, Iss. 3
Open Access
Protein Oxidative Modifications in Neurodegenerative Diseases: From Advances in Detection and Modelling to Their Use as Disease Biomarkers
Sandra I. Anjo, Zhicheng He, Zohaib Hussain, et al.
Antioxidants (2024) Vol. 13, Iss. 6, pp. 681-681
Open Access | Times Cited: 4
Clinical Proteomics: A Promise Becoming Reality
Michael A. Gillette, Connie R. Jiménez, Steven A. Carr
Molecular & Cellular Proteomics (2024) Vol. 23, Iss. 2, pp. 100688-100688
Open Access | Times Cited: 2
Performance of Fully-Automated High-Throughput Plasma Biomarker Assays for Alzheimer’s Disease in Amnestic Mild Cognitive Impairment Subjects
Guido Maria Giuffrè, Davide Quaranta, Maria Gabriella Vita, et al.
The Journal of Prevention of Alzheimer s Disease (2024)
Open Access | Times Cited: 2
Fluid biomarkers unveil signatures of pathological aging
Niels Hansen, Jens Wiltfang
Seizure (2024)
Open Access | Times Cited: 1
Predicting Role of GFAP and UCH-L1 biomarkers in Spontaneous Subarachnoid Hemorrhage: a preliminary study to evaluate in the short-term their correlation with severity of bleeding and prognosis
Annamaria Auricchio, Silvia Baroni, Behnam Rezai Jahromi, et al.
Journal of Clinical Neuroscience (2024) Vol. 126, pp. 119-127
Closed Access | Times Cited: 1
Performance of plasma p-tau217 for the detection of amyloid-β positivity in a memory clinic cohort using an electrochemiluminescence immunoassay
Adam H. Dyer, Helena Dolphin, Antoinette O’Connor, et al.
Alzheimer s Research & Therapy (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 1
The Immune Signature of CSF in Multiple Sclerosis with and without Oligoclonal Bands: A Machine Learning Approach to Proximity Extension Assay Analysis
Lorenzo Gaetani, G. Bellomo, Elena Di Sabatino, et al.
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 139-139
Open Access | Times Cited: 4
Validating blood tests as a possible routine diagnostic assay of Alzheimer’s disease
Eleftheria Kodosaki, Henrik Zetterberg, Amanda Heslegrave
Expert Review of Molecular Diagnostics (2023) Vol. 23, Iss. 12, pp. 1153-1165
Open Access | Times Cited: 3
Isolation and Identification of the High-Affinity DNA Aptamer Target to the Brain-Derived Neurotrophic Factor (BDNF)
Anisuzzaman Chowdhury, Jessica M. Collins, David A. Gell, et al.
ACS Chemical Neuroscience (2023) Vol. 15, Iss. 2, pp. 346-356
Closed Access | Times Cited: 2
High-dimensional proteomic analysis for pathophysiological classification of Traumatic Brain Injury
Lucia M. Li, Eleftheria Kodosaki, Amanda Heselgrave, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access
A Comprehensive Review of the Role of Biomarkers in the Early Detection of Endocrine Disorders in Critical Illnesses
Pallavi Deulkar, Amol Singam, Abhishek Jain
Cureus (2024)
Open Access
Biomarker-Based Prediction of Parkinson Disease
Lucilla Parnetti, Lorenzo Gaetani
Neurology (2024) Vol. 103, Iss. 3
Closed Access
Analytical and clinical performance of eight Simoa® and Lumipulse® assays for automated measurement of plasma p-tau181 and p-tau217
Anna Lidia Wojdaƚa, Jeroen Vanbrabant, Sherif Bayoumy, et al.
Alzheimer s Research & Therapy (2024) Vol. 16, Iss. 1
Open Access
Decision Tree for Protein Biomarker Selection for Clinical Applications
Katharina Waury
Methods in molecular biology (2024), pp. 355-368
Closed Access
Page 1

Scroll to top